EN | RU
EN | RU

Help Support

Back

Study assesses efficacy of nociceptive trigeminal inhibition splint in chronic migraine people

nociceptive_trigeminal_inhibition_device nociceptive_trigeminal_inhibition_device
nociceptive_trigeminal_inhibition_device nociceptive_trigeminal_inhibition_device

What's new?

A nociceptive trigeminal inhibition device can be considered as a method of determining if jaw-clenching is a significant contributing factor to ongoing migraine.

According to a placebo-controlled, cross-over, single-blinded study published in BMC Neurology,

the improvement in headache impact test (HIT-6) scores induced by nociceptive trigeminal inhibition (NTI) device indicated that refractory chronic migraine sufferers might have intense nocturnal jaw clenching as a contributory factor to their headache linked disability.

Researchers aimed to determine migraine prevention effectiveness of NTI oral device (a dental splint designed to decrease the intensity of nocturnal jaw clenching) vs. placebo in 30 people suffering from chronic migraine. Each participant was treated with either an NTI device or a placebo device. An alteration in the HIT-6 score was the endpoint of the study.

Table 1 shows the percentage of migraine patients utilizing NTI splint that exhibited at least one-category improvement and two-category improvement in their HIT-6 scores.

Thus, an NTI device appears to be beneficial to assess if jaw-clenching is a contributing factor to ongoing migraine.

Source:

BMC Neurology

Article:

Adjunctive treatment of chronic migraine using an oral dental device: overview and results of a randomized placebo-controlled crossover study

Authors:

Andrew M Blumenfeld et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: